Consolidated Statements of Profit or Loss and Other Comprehensive Income
For the Three-Month Period Ended
December 31, | For the Year Ended
December 31, | |||||||||||||||
2019 | 2020 | 2019 | 2020 | |||||||||||||
Thousand
USD | Thousand
USD | Thousand
USD | Thousand
USD | |||||||||||||
Revenues | 1,977 | 1,971 | 7,070 | 3,399 | ||||||||||||
Cost of revenues | 1,129 | 673 | 4,312 | 1,563 | ||||||||||||
Cost of revenues - amortization of intangible | 193 | 192 | 772 | 771 | ||||||||||||
Total cost of revenues | 1,322 | 865 | 5,084 | 2,334 | ||||||||||||
Gross profit | 655 | 1,106 | 1,986 | 1,065 | ||||||||||||
Research and development expenses, net | 1,525 | 3,725 | 8,082 | 9,878 | ||||||||||||
Sales and marketing expenses | 1,381 | 2,373 | 5,469 | 6,597 | ||||||||||||
General and administrative expenses | 881 | 3,539 | 3,270 | 20,287 | ||||||||||||
Operating loss | (3,132 | ) | (8,531 | ) | (14,835 | ) | (35,697 | ) | ||||||||
Finance income | 1,842 | 275 | 8,765 | 446 | ||||||||||||
Finance expense | 91 | 9,183 | 2,283 | 13,243 | ||||||||||||
Total comprehensive loss | (1,381 | ) | (17,439 | ) | (8,353 | ) | (48,494 | ) | ||||||||
Basic loss per share (in USD) (after 1:50 reverse split effective June 29, 2020) | (0.35 | ) | (0.20 | ) | (2.38 | ) | (1.13 | ) |